SEC Form 4 · accession 0001022079-26-000053
QUEST DIAGNOSTICS INC · DGX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Karthik Kuppusamy
Officer — SVP, Clinical Solutions
Period of report
Jun 4, 2026
Accepted (ET)
Jun 8, 2026 · 4:32 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001022079
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 4, 2026 | M | 3,320 | $127.725 | A | 16,830 | D | |
| Common Stock | Jun 4, 2026 | M | 4,827 | $121.805 | A | 21,657 | D | |
| Common StockF2 | Jun 4, 2026 | S | 8,147 | $200.00 | D | 13,510 | D | |
| Common StockF3 | holding | — | — | — | 1,721 | I | 401(k) | |
| Common Stock | holding | — | — | — | 358 | I | By Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualifed Stock Option (right to buy)F4 | $127.725 | Jun 4, 2026 | M | 3,320 | D | — | Feb 24, 2032 | Common Stock | 3,320 | 0 | D |
| Non-Qualifed Stock Option (right to buy)F5 | $121.805 | Jun 4, 2026 | M | 4,827 | D | — | Feb 17, 2031 | Common Stock | 4,827 | 0 | D |
Explanation of responses
- F1This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.
- F2The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4.
- F3These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under the Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date.
- F4The options vested in three annual installments beginning with the first on February 24, 2023, the second on February 24, 2024 and the final on February 24, 2025.
- F5The options vested in three annual installments beginning with the first on February 17, 2022, the second on February 17, 2023 and the final on February 17, 2024.